Insider Trading History of Assouline, Eliav

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Assouline, Eliav since 2010. The trader's CIK number is 1483841. At the time of the last reporting, Assouline, Eliav was the Officer of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF). Also see all insider trading activities at Novelion Therapeutics Inc..


Yearly summary of insider trading at Novelion Therapeutics Inc. (QLTI) by Assouline, Eliav

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 QLTI 0 $0 8,865,036 $30,770,539 0 $0
2011 QLTI 2,000,000 $14,497,250 0 $0 0 $0
2010 QLTI 1,394,007 $8,127,075 0 $0 0 $0


Insider trading of Novelion Therapeutics Inc. (QLTI) by Assouline, Eliav

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-16 QLTI Sale 8,865,036 3.47 30,770,539
2011-08-29 QLTI Buy 1,725,000 7.25 12,506,250
2011-08-30 QLTI Buy 275,000 7.24 1,991,000
2010-11-11 QLTI Buy 72,100 5.72 412,412
2010-11-08 QLTI Buy 4,300 5.60 24,080
2010-11-03 QLTI Buy 2,600 5.60 14,559
2010-11-03 QLTI Buy 2,600 5.60 14,559
2010-11-03 QLTI Buy 2,600 5.60 14,559
2010-11-01 QLTI Buy 65,000 5.70 370,500
2010-10-29 QLTI Buy 65,000 5.62 365,300
2010-11-02 QLTI Buy 41,000 5.78 236,980
2010-08-31 QLTI Buy 60,506 5.75 347,909
2010-09-01 QLTI Buy 5,318 5.75 30,578
2010-08-30 QLTI Buy 7,400 5.70 42,180
2010-08-26 QLTI Buy 50,000 5.67 283,500
2010-08-27 QLTI Buy 50,000 5.78 289,000
2010-08-11 QLTI Buy 100,000 5.70 570,000
2010-07-30 QLTI Buy 37,226 5.72 212,932
2010-07-06 QLTI Buy 109,157 5.79 632,019
2010-07-02 QLTI Buy 200,000 5.73 1,146,000
2010-06-30 QLTI Buy 139,200 5.74 799,008
2010-07-01 QLTI Buy 80,000 5.75 460,000
2010-06-04 QLTI Buy 100,000 6.24 624,000
2010-06-07 QLTI Buy 100,000 6.27 627,000
2010-06-08 QLTI Buy 100,000 6.10 610,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Assouline, Eliav (Officer of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.